Cagrilintide is not associated with clinically relevant <scp>QTc</scp> prolongation: A thorough <scp>QT</scp> study in healthy participants
Cagrilintide did not result in clinically relevant QTcF prolongation, indicating no increased risk of ventricular tachyarrhythmias.
Authors
- Angela Sinn
- Kasper K. Berthelsen
- Rainard Fuhr
- Tine A. Bækdal (ORCID: https://orcid.org/0000-0002-1348-0352)
- Anja Birk Kuhlman (ORCID: https://orcid.org/0000-0001-8893-8498)
- M Gabe (ORCID: https://orcid.org/0000-0003-2559-862X)
- Astrid Eliasen (ORCID: https://orcid.org/0000-0002-2261-0323)
- A Nejad (ORCID: https://orcid.org/0000-0003-4688-7877)
Institutions
- Novo Nordisk (Denmark) (DK)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2024-09-16
- DOI
- https://doi.org/10.1111/dom.15951
- Citations
- 1
- Primary Topic
- Cardiac electrophysiology and arrhythmias
- Type
- article
- Field-Weighted Citation Impact
- 0.40